WEVO & Xeno Biosciences

At its meeting on Tuesday, February 12, 2019, Beacon Angels entertained funding proposals from: 

  • WEVO, a company that enables marketers to evaluate and enhance digital experiences without the need for live traffic, disrupting the traditional market research and AB testing tools. and
  • Xeno Biosciences, which has a disruptive approach to treating obesity that mimics the highly successful treatment of gastric bypass surgery using a simple enteric-coated pill composed of components that have been shown to be safe in man. It induces the same microbiome changes caused by the surgery resulting in weight loss.

We also entertained members’ portfolio updates and a presentation on The Capital Network.

About Beacon Angels

Angel group, founded in 2006, that invests in early stage start-up companies--New England based only.
This entry was posted in Beacon Angels Events, Funding Presentations, Uncategorized and tagged , , . Bookmark the permalink.